Suppr超能文献

全面药师主导的出院过渡期药物管理相对于常规护理会增加适度成本:时间和动作成本分析。

Comprehensive Pharmacist-led Transitions-of-care Medication Management around Hospital Discharge Adds Modest Cost Relative to Usual Care: Time-and-Motion Cost Analysis.

机构信息

Cedars-Sinai Medical Center, Los Angeles, CA, USA.

University of Connecticut, Storrs, CT, USA.

出版信息

Inquiry. 2023 Jan-Dec;60:469580231218625. doi: 10.1177/00469580231218625.

Abstract

Optimal medication management is important during hospitalization and at discharge because post-discharge adverse drug events (ADEs) are common, often preventable, and contribute to patient harms, healthcare utilization, and costs. Conduct a cost analysis of a comprehensive pharmacist-led transitions-of-care medication management intervention for older adults during and after hospital discharge. Twelve intervention components addressed medication reconciliation, medication review, and medication adherence. Trained, experienced pharmacists delivered the intervention to older adults with chronic comorbidities at 2 large U.S. academic centers. To quantify and categorize time spent on the intervention, we conducted a time-and-motion analysis of study pharmacists over 36 sequential workdays (14 519 min) involving 117 patients. For 40 patients' hospitalizations, we observed all intervention activities. We used the median minutes spent and pharmacist wages nationally to calculate cost per hospitalization (2020 U.S. dollars) from the hospital perspective, relative to usual care. Pharmacists spent a median of 66.9 min per hospitalization (interquartile range 46.1-90.1), equating to $101 ($86 to $116 in sensitivity analyses). In unadjusted analyses, study site was associated with time spent (medians 111 and 51.8 min) while patient primary language, discharge disposition, number of outpatient medications, and patient age were not. In this cost analysis, comprehensive medication management around discharge cost about $101 per hospitalization, with variation across sites. This cost is at least an order of magnitude less than published costs associated with ADEs, hospital readmissions, or other interventions designed to reduce readmissions. Work is ongoing to assess the current intervention's effectiveness.

摘要

优化药物管理在住院期间和出院时非常重要,因为出院后药物不良事件(ADE)很常见,往往是可以预防的,并且会导致患者伤害、医疗保健利用和成本增加。对一项由药师主导的综合性过渡护理药物管理干预措施在老年人住院期间和出院后的成本进行分析。该干预措施有 12 个组成部分,用于解决药物重整、药物审查和药物依从性问题。经过培训的、经验丰富的药师在美国 2 家大型学术中心为患有慢性共病的老年人提供了该干预措施。为了量化和分类干预措施所花费的时间,我们对研究药师在 36 个连续工作日(14519 分钟)内的工作进行了时间和运动分析,涉及 117 名患者。对于 40 名患者的住院治疗,我们观察了所有的干预活动。我们使用中位数分钟数和全国药师工资计算了从医院角度来看,每例住院治疗的成本(2020 年美元),相对于常规护理。药师每例住院治疗花费中位数为 66.9 分钟(四分位距 46.1-90.1),相当于 101 美元(敏感性分析中为 86 至 116 美元)。在未调整的分析中,研究地点与所花费的时间相关(中位数分别为 111 和 51.8 分钟),而患者的主要语言、出院处置、门诊药物数量和患者年龄则没有。在这项成本分析中,出院前后的综合药物管理费用约为每例住院治疗 101 美元,各地点之间存在差异。这一成本至少比与 ADE、医院再入院或其他旨在减少再入院的干预措施相关的已发表成本低一个数量级。目前正在开展工作以评估当前干预措施的效果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f76c/10752096/c63db79d2e8c/10.1177_00469580231218625-fig1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验